R97 — Abnormal tumor markers
Not billable
Is R97 billable?
No — R97 is a non-billable header code. R97 groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 5 billable codes beneath R97.
R97 at a glance
| Code | R97 |
|---|---|
| Description | Abnormal tumor markers |
| Billable | No — header code |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Inclusion terms
Alternative wording in documentation that is classified to R97.
- Elevated tumor associated antigens [TAA]
- Elevated tumor specific antigens [TSA]
Excludes2 — not included here — inherited from Chapter 18
The conditions below are not part of R97, but a patient may have both at the same time. When documentation supports it, R97 and the excluded code may both be reported.
What codes fall under R97? (4)
How long has R97 existed?
R97 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.